10x Genomics projected up to 4% revenue growth for 2026 and warned that constrained capital spending among customers will continue to pressure instrument revenue, while consumables demand — especially single‑cell and spatial reagents — remains the company’s growth driver. Management cited persistent funding headwinds for capital purchases but highlighted sustained consumables pull‑through. In complementary technology news, Broad Institute scientists Fei Chen and Chenlei Hu unveiled an imaging‑free spatial transcriptomics method that reconstructs tissue maps using barcode diffusion and sequencing, a technique aimed at scaling spatial profiling without high-end microscopy. Together, the corporate guidance and the new method underscore a push to expand spatial biology access and throughput across labs.